95 related articles for article (PubMed ID: 38613897)
21. Mechanisms of resistance to chemotherapy in non-small cell lung cancer.
Min HY; Lee HY
Arch Pharm Res; 2021 Feb; 44(2):146-164. PubMed ID: 33608812
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation.
Ferreira JA; Peixoto A; Neves M; Gaiteiro C; Reis CA; Assaraf YG; Santos LL
Drug Resist Updat; 2016 Jan; 24():34-54. PubMed ID: 26830314
[TBL] [Abstract][Full Text] [Related]
23. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
24. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
25. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells.
Alimbetov D; Askarova S; Umbayev B; Davis T; Kipling D
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882812
[TBL] [Abstract][Full Text] [Related]
27. ABCG2: the key to chemoresistance in cancer stem cells?
An Y; Ongkeko WM
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1529-42. PubMed ID: 19708828
[TBL] [Abstract][Full Text] [Related]
28. Physiological modulation approaches to improve cancer chemotherapy : a review.
Kumar R; Kaur M; Silakari O
Anticancer Agents Med Chem; 2014 Jun; 14(5):713-49. PubMed ID: 24117110
[TBL] [Abstract][Full Text] [Related]
29. ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy.
Dlugosz A; Janecka A
Curr Pharm Des; 2016; 22(30):4705-4716. PubMed ID: 26932159
[TBL] [Abstract][Full Text] [Related]
30. Emerging role of NRF2 in ROS-mediated tumor chemoresistance.
Xue D; Zhou X; Qiu J
Biomed Pharmacother; 2020 Nov; 131():110676. PubMed ID: 32858502
[TBL] [Abstract][Full Text] [Related]
31. Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology.
Xue X; Liang XJ
Chin J Cancer; 2012 Feb; 31(2):100-9. PubMed ID: 22237039
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms for tumour resistance to chemotherapy.
Pan ST; Li ZL; He ZX; Qiu JX; Zhou SF
Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):723-37. PubMed ID: 27097837
[TBL] [Abstract][Full Text] [Related]
33. Tumour Cell Secretome in Chemoresistance and Tumour Recurrence.
Madden EC; Gorman AM; Logue SE; Samali A
Trends Cancer; 2020 Jun; 6(6):489-505. PubMed ID: 32460003
[TBL] [Abstract][Full Text] [Related]
34. Cancer chemoresistance; biochemical and molecular aspects: a brief overview.
Kachalaki S; Ebrahimi M; Mohamed Khosroshahi L; Mohammadinejad S; Baradaran B
Eur J Pharm Sci; 2016 Jun; 89():20-30. PubMed ID: 27094906
[TBL] [Abstract][Full Text] [Related]
35. Proteomics for identifying mechanisms and biomarkers of drug resistance in cancer.
Li XH; Li C; Xiao ZQ
J Proteomics; 2011 Nov; 74(12):2642-9. PubMed ID: 21964283
[TBL] [Abstract][Full Text] [Related]
36. Cancer stem cell epigenetics and chemoresistance.
Crea F; Danesi R; Farrar WL
Epigenomics; 2009 Oct; 1(1):63-79. PubMed ID: 22122637
[TBL] [Abstract][Full Text] [Related]
37. ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.
Begicevic RR; Falasca M
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29117122
[TBL] [Abstract][Full Text] [Related]
38. Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role.
Kannampuzha S; Gopalakrishnan AV
Med Oncol; 2023 Aug; 40(9):264. PubMed ID: 37550533
[TBL] [Abstract][Full Text] [Related]
39. Targeting mitochondria as a potential therapeutic strategy against chemoresistance in cancer.
Mukherjee S; Bhatti GK; Chhabra R; Reddy PH; Bhatti JS
Biomed Pharmacother; 2023 Apr; 160():114398. PubMed ID: 36773523
[TBL] [Abstract][Full Text] [Related]
40. Cancer stem cells and chemoresistance: The smartest survives the raid.
Zhao J
Pharmacol Ther; 2016 Apr; 160():145-58. PubMed ID: 26899500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]